Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

The relationship of coffee consumption with mortality.

Lopez-Garcia E, van Dam RM, Li TY, Rodriguez-Artalejo F, Hu FB.

Ann Intern Med. 2008 Jun 17;148(12):904-14.

2.

Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways.

Gressner OA, Lahme B, Rehbein K, Siluschek M, Weiskirchen R, Gressner AM.

J Hepatol. 2008 Nov;49(5):758-67. doi: 10.1016/j.jhep.2008.03.029. Epub 2008 Apr 30.

PMID:
18486259
3.
4.

Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver.

Huber WW, Rossmanith W, Grusch M, Haslinger E, Prustomersky S, Peter-Vörösmarty B, Parzefall W, Scharf G, Schulte-Hermann R.

Food Chem Toxicol. 2008 Apr;46(4):1230-8. Epub 2007 Sep 25.

PMID:
17983700
5.

Induction of Nrf2-mediated cellular defenses and alteration of phase I activities as mechanisms of chemoprotective effects of coffee in the liver.

Cavin C, Marin-Kuan M, Langouët S, Bezençon C, Guignard G, Verguet C, Piguet D, Holzhäuser D, Cornaz R, Schilter B.

Food Chem Toxicol. 2008 Apr;46(4):1239-48. Epub 2007 Sep 26.

PMID:
17976884
6.
7.

Coffee drinking and hepatocellular carcinoma risk: a meta-analysis.

Bravi F, Bosetti C, Tavani A, Bagnardi V, Gallus S, Negri E, Franceschi S, La Vecchia C.

Hepatology. 2007 Aug;46(2):430-5.

PMID:
17580359
8.

Coffee consumption and risk of liver cancer: a meta-analysis.

Larsson SC, Wolk A.

Gastroenterology. 2007 May;132(5):1740-5. Epub 2007 Mar 24.

PMID:
17484871
9.

Coffee, cirrhosis, and transaminase enzymes.

Klatsky AL, Morton C, Udaltsova N, Friedman GD.

Arch Intern Med. 2006 Jun 12;166(11):1190-5.

PMID:
16772246
10.

The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults.

Iso H, Date C, Wakai K, Fukui M, Tamakoshi A; JACC Study Group.

Ann Intern Med. 2006 Apr 18;144(8):554-62.

PMID:
16618952
11.

Green tea consumption in everyday life and mental health.

Shimbo M, Nakamura K, Jing Shi H, Kizuki M, Seino K, Inose T, Takano T.

Public Health Nutr. 2005 Dec;8(8):1300-6.

PMID:
16372926
12.
13.

Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study.

Gelatti U, Covolo L, Franceschini M, Pirali F, Tagger A, Ribero ML, Trevisi P, Martelli C, Nardi G, Donato F; Brescia HCC Study Group.

J Hepatol. 2005 Apr;42(4):528-34.

PMID:
15868652
14.

Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan.

Shimazu T, Tsubono Y, Kuriyama S, Ohmori K, Koizumi Y, Nishino Y, Shibuya D, Tsuji I.

Int J Cancer. 2005 Aug 10;116(1):150-4.

15.

Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan.

Inoue M, Yoshimi I, Sobue T, Tsugane S; JPHC Study Group.

J Natl Cancer Inst. 2005 Feb 16;97(4):293-300.

PMID:
15713964
16.

Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer.

Michels KB, Willett WC, Fuchs CS, Giovannucci E.

J Natl Cancer Inst. 2005 Feb 16;97(4):282-92.

17.

Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N-nitrosodimethylamine in a human derived liver cell line (HepG2).

Majer BJ, Hofer E, Cavin C, Lhoste E, Uhl M, Glatt HR, Meinl W, Knasmüller S.

Food Chem Toxicol. 2005 Mar;43(3):433-41.

PMID:
15680679
18.
19.

Coffee intake and mortality from liver cirrhosis.

Tverdal A, Skurtveit S.

Ann Epidemiol. 2003 Jul;13(6):419-23.

PMID:
12875799
20.

Does coffee protect against hepatocellular carcinoma?

Gallus S, Bertuzzi M, Tavani A, Bosetti C, Negri E, La Vecchia C, Lagiou P, Trichopoulos D.

Br J Cancer. 2002 Oct 21;87(9):956-9.

Supplemental Content

Support Center